Activin and Inhibin

FHT-1205 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC 50 s of ≤10 nM (WO2020160180A1: compound 67).Form:Solid.

FHT-1205 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC 50 s of ≤10 nM (WO2020160180A1: compound 67).Form:Solid.

FHT-1205 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC 50 s of ≤10 nM (WO2020160180A1: compound 67).

FHT-1204 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC 50 s of ≤10 nM (WO2020160180A1: compound 70).Form:Solid.

FHT-1204 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC 50 s of ≤10 nM (WO2020160180A1: compound 70).Form:Solid.

FHT-1204 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC 50 s of ≤10 nM (WO2020160180A1: compound 70).

Fiboflapon (GSK2190915: AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein ( FLAP ) inhibitor with a potency of 2.9 nM in FLAP binding, an IC 50 of 76 nM for inhibition of LTB4 in human bloodIn VitroFiboflapon (AM-803)

Fiboflapon (GSK2190915: AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein ( FLAP ) inhibitor with a potency of 2.9 nM in FLAP binding, an IC 50 of 76 nM for inhibition of LTB4 in human bloodIn VitroFiboflapon (AM-803)

Fiboflapon (GSK2190915: AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein ( FLAP ) inhibitor with a potency of 2.9 nM in FLAP binding, an IC 50 of 76 nM for inhibition of LTB4 in human bloodIn VitroFiboflapon (AM-803)

Fiboflapon (GSK2190915: AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein ( FLAP ) inhibitor with a potency of 2.9 nM in FLAP binding, an IC 50 of 76 nM for inhibition of LTB4 in human bloodIn VitroFiboflapon (AM-803)

Fiboflapon (GSK2190915: AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein ( FLAP ) inhibitor with a potency of 2.9 nM in FLAP binding, an IC 50 of 76 nM for inhibition of LTB4 in human bloodIn VitroFiboflapon (AM-803)

Fiboflapon sodium (GSK2190915: AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein ( FLAP ) inhibitor with a potency of 2.9 nM in FLAP binding, an IC 50 of 76 nM for inhibition of LTB4 in human bloodIn VitroFiboflapon